José Francisco Pereira Cardoso

José Francisco Pereira Cardoso

Auto-generated profile, based on publicly available information

José Francisco Pereira Cardoso

Faculty of Medicine, Department of Dermatology and Venereology, Lund University, Lund, Sweden

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2021 in Scandinavian Journal of Urology
Verified
Journal Article
Open access
AFAndreas Forsvall
Andreas Forsvall
JFJane Fisher
Jane Fisher
JCJosé Francisco Pereira Cardoso
José Francisco Pereira Cardoso
MWMagnus Wagenius
Magnus Wagenius
JTJonas Tverring
Jonas Tverring
TMTirthankar Mohanty
Tirthankar Mohanty
Transrectal prostate biopsy (TRbx) transfers colonic bacteria into prostatic tissue, potentially causing infectious complications, including sepsis. Our objective was to determine whether biopsy ne...

7 December 2025 in The Journal of Vascular Access
Verified
Journal Article
Open access
HPHåkan Pärsson
Håkan Pärsson
MWMagnus Wagenius
Magnus Wagenius
MUMaria Utter
Maria Utter
JTJonas Tverring
Jonas Tverring
JCJosé Francisco Pereira Cardoso
José Francisco Pereira Cardoso
AFAndreas Forsvall
Andreas Forsvall
Background: Totally implantable venous access ports (TIVAPs) are essential for administering chemotherapeutic drugs and nutritional support, but carry a risk of infectious complications. We hypothesized that the design of the current port needle (Huber) could facilitate the collection of bacteria from the skin during puncture, potentially introducing them into TIVAPs and causing infections. This study examines bacterial transfer via needles during TIVAP access and proposes a novel needle design to reduce the risk of infection. Methods: A novel needle, the Forsvall Port needle, was developed with a closed tip to reduce bacterial transmission inside the needle during tissue and port penetration. In a randomized ex vivo setting, human skin samples covered in physiological levels of Staphylococcus aureus were placed over port membranes and punctured repeatedly by the standard Huber needle and the Forsvall Port needle. Cultures from the needle tips were plated after puncture and used to compare bacterial transfer into TIVAPs using a generalized linear mixed-effects model. Punctures were performed in a separate human skin to examine the mechanism of bacterial transfer. Results: The Forsvall Port needle reduced average bacterial transfer by 87.0% (95% CI: 77.8%–92.4%, p < 0.0001) compared with the Huber needle, based on 10 punctures per needle across four skin samples. Additional testing on a separate skin sample showed that a defectively fitted Forsvall Port needle prototype did not reduce bacterial transfer relative to the Huber needle (95% CI: 58.3% decrease to 30.0% increase, p = 0.289), whereas a steel rod simulating a perfectly closed Forsvall Port needle achieved a 99.9% (95% CI: 99.5%–100%, p < 0.0001) reduction in bacterial transfer. Conclusion: The Forsvall Port needle significantly reduces bacterial transfer into TIVAPs, which could potentially decrease TIVAP-related infections. This study demonstrates a strong association between needle design and bacterial transfer during TIVAP access.